The effect of a novel viscous polysaccharide along with lifestyle changes on short-term weight loss and associated risk factors in overweight and obese adults: An observational retrospective clinical program analysis

Alternative Medicine Review

Volumn 15, Issue 1, 2010, Pages 68-75

  Lyon, Michael R ^a,b   Reichert, Ronald G ^a  

^a Canadian Centre for Functional Medicine   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

BMI; Metabolic syndrome; Obesity; PGX; Viscous fiber; Weight loss

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYGLYCOPLEX; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MALE; OBESITY; OBSERVATIONAL STUDY; VISCOSITY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; BODY WEIGHT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIFE STYLE; MALE; MANNANS; MIDDLE AGED; OBESITY; POLYSACCHARIDES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISCOSITY; WEIGHT LOSS; YOUNG ADULT;

EID: 77952481154     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. http://www.who.int/mediacentre/factsheets/fs311/en/index.html [Accessed January 29, 2010]
2. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obesity Res 2002;10:116S-123S.
3. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32.
4. Skender ML, Goodrick GK, Del Junco DJ, et al. Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc 1996;96:342-346.
5. Curioni CC, Lourenço PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond) 2005;29:1168-1174. (Pubitemid 43080294)
6. Queenan KM, Stewart ML, Smith KN, et al. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007;6:6.
7. Shamliyan TA, Jacobs DR Jr, Raatz SK, et al. Are your patients with risk of CVD getting the viscous soluble fiber they need? J Fam Pract 2006;55:761-769.
8. Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 2001;110:724-730. (Pubitemid 32524322)
9. Keithley J, Swanson B. Glucomannan and obesity: a critical review. Altern Ther Health Med 2005;11:30-34.
10. Birketvedt GS, Shimshi M, Erling T, Florholmen J. Experiences with three different fiber supplements in weight reduction. Med Sci Monit 2005;11:PI5-P18.
11. Rodríguez-Morán M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago psyllium in type II diabetes. J Diabetes Complications 1998;12:273-278. (Pubitemid 28423398)
12. Keenan JM, Goulson M, Shamliyan T, et al. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women. Br J Nutr 2007;97:1162-1168. (Pubitemid 46925369)
13. Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, et al. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 2007;14:203-212. (Pubitemid 46597661)
14. Jenkins DJ, Kendall CW, Faulkner DA, et al. Long-term effects of a plant-based dietary portfolio of cholesterol-lowering foods on blood pressure. Eur J Clin Nutr 2008;62:781-788.
15. Jenkins DJ, Kendall CW, Marchie A, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 2005;81:380-387. (Pubitemid 43073339)
16. Vuksan V, Lyon M, Breitman P, Sievenpiper J. 3-week consumption of a highly viscous dietary fibre blend results in improvements in insulin sensitivity and reductions in body fat: results of a double-blind, placebo controlled trial. Presented at the 64th Annual Meeting of the American Diabetes Association. Orlando, Florida; June 4-8, 2004.
17. Breitman P, Vuksan V, Lyon M, et al. Impact of meal replacement viscosity on appetite and ad libitum food consumption in normal weight adolescents. Presented at the 8th Annual Canadian Diabetes Association (CDA)/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference. Quebec City, Quebec; October 27-30, 2004.
18. Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 1999;22:913-919.
19. Rogovik A, Jenkins AL, Breitman P, Vuksan V. A blend of highly viscous polysaccharides decreases relative CVD risk in healthy individuals and those with diabetes and metabolic syndrome. Presented at the Natural Health Product Research Conference. Toronto, ON; March 3-5, 2006.
20. Vuksan V, Panahi S, Lyon M, et al. Viscosity of fiber preloads affects food intake in adolescents. Nutr Metab Cardiovasc Dis 2009;19:498-503.
21. Hoad CL, Rayment P, Spiller RC, et al. In vivo imaging of intragastric gelation and its effect on satiety in humans. J Nutr 2004;134:2293-2300.
22. Pereira MA, Ludwig DS. Dietary fiber and body-weight regulation. Observations and mechanisms. Pediatr Clin North Am 2001;48:969-980.
23. Juvonen KR, Purhonen AK, Salmenkallio-Marttila M, et al. Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans. J Nutr 2009;139:461-466.
24. Carabin IG, Lyon MR, Wood S, et al. Supplementation of the diet with the functional fiber PolyGlycopleX® is well tolerated by healthy subjects in a clinical trial. Nutr J 2009;8:9.
25. Kraemer WJ, Vingren JL, Silvestre R, et al. Effect of adding exercise to a diet containing glucomannan. Metabolism 2007;56:1149-1158.
26. Krotkiewski M. Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects. Br J Nutr 1984;52:97-105. (Pubitemid 14052360)
27. Salas-Salvadó J, Farrés X, Luque X, et al. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr 2008;99:1380-1387.
28. Ferraro R, Lillioja S, Fontvieille AM, et al. Lower sedentary metabolic rate in women compared with men. J Clin Invest 1992;90:780-784.
29. Dixon JB. Weight loss medications - where do they fit in? Aust Fam Physician 2006;35:576-579.
30. Anderson JW, Schwartz SM, Hauptman J, et al. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial. Ann Pharmacother 2006;40:1717-1723. (Pubitemid 44544866)
31. Kannel WB, D'Agostino RB, Stepanians M, D'Agostino LC. Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status. Am J Cardiol 1990;66:1B-10B.
32. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome - from insulin resistance to obesity and diabetes. Endocrinol Metab Clin North Am 2008;37:559-579.
33. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62. (Pubitemid 40299773)
34. Šabovič M, Lavre S, Keber I. Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome. Eur J Cardiovasc Prev Rehabil 2004;11:144-148. (Pubitemid 38591085)
35. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004;59:207-223. (Pubitemid 41327152)